Literature DB >> 17932988

Complete fatty degeneration of lumbar erector spinae muscles caused by a primary dysferlinopathy.

P Seror1, M Krahn, P Laforet, F Leturcq, T Maisonobe.   

Abstract

Magnetic resonance imaging of the thoracolumbar spine showed complete fatty degeneration of the lumbar erector spinae muscles in a woman who had complained of chronic lower back pain for 5 years and of progressive weakness of the lower limbs for 1 year. Neuromuscular examination of the lower limbs showed no obvious anomaly, and there was no camptocormia. Serum creatine kinase levels were increased (six- to ninefold); electrodiagnostic examination revealed no activity at rest or during effort in the erector spinae muscles and was normal in proximal and distal muscles of the limbs. Muscle computed tomography revealed mild fatty degeneration of thigh and gastrocnemius muscles, and histopathology of the deltoid muscle showed dystrophic features and complete lack of dysferlin. Molecular analysis identified a homozygous disease-causing mutation in the gene encoding dysferlin. Because there were no similar cases in the family, the final diagnosis was sporadic limb-girdle muscular dystrophy type 2B. Overall, this case report shows that the lumbar and lower thoracic of erector spinae muscles may display complete fatty degeneration without the occurrence of camptocormia, with primary dysferlin deficiency as a possible cause.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17932988     DOI: 10.1002/mus.20910

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Novel diagnostic features of dysferlinopathies.

Authors:  Xiomara Q Rosales; Julie M Gastier-Foster; Sarah Lewis; Malik Vinod; Devon L Thrush; Caroline Astbury; Robert Pyatt; Shalini Reshmi; Zarife Sahenk; Jerry R Mendell
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

2.  [Causes of camptocormia].

Authors:  F X Glocker; U G Berninger
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

3.  Camptocormia phenotype of FSHD: a clinical and MRI study on six patients.

Authors:  Berit Jordan; Katharina Eger; Sabrina Koesling; Stephan Zierz
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

4.  Camptocormia as a clinical manifestation of polymyositis/systemic sclerosis overlap myositis associated with anti-Ku.

Authors:  Thierry Zenone; Nathalie Streichenberger; Marie Puget
Journal:  Rheumatol Int       Date:  2012-03-28       Impact factor: 2.631

5.  Painful camptocormia: the relevance of shaking your patient's hand.

Authors:  Arnaud Dupeyron; Nina Stober; Anthony Gelis; Giovani Castelnovo; Pierre Labauge; Jacques Pélissier
Journal:  Eur Spine J       Date:  2009-07-10       Impact factor: 3.134

6.  Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer.

Authors:  William E Grose; K Reed Clark; Danielle Griffin; Vinod Malik; Kimberly M Shontz; Chrystal L Montgomery; Sarah Lewis; Robert H Brown; Paul M L Janssen; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

7.  AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models.

Authors:  Patricia C Sondergaard; Danielle A Griffin; Eric R Pozsgai; Ryan W Johnson; William E Grose; Kristin N Heller; Kim M Shontz; Chrystal L Montgomery; Joseph Liu; Kelly Reed Clark; Zarife Sahenk; Jerry R Mendell; Louise R Rodino-Klapac
Journal:  Ann Clin Transl Neurol       Date:  2015-01-20       Impact factor: 4.511

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.